Section Arrow
Quote
RDY.NYSE
- Dr. Reddy's Laboratories Ltd
Quotes are at least 15-min delayed:2026/09/24 16:14 EDT
After Hours
Last
 12.3
-- (--)
Bid
12.15
Ask
12.48
High 12.3 
Low 12.3 
Volume 19.76K 
Regular Hours (Closed)
Last
 12.295
-0.095 (-0.77%)
Day High 
12.44 
Prev. Close
12.39 
1-M High
12.72 
Volume 
3.04M 
Bid
12.15
Ask
12.48
Day Low
12.2501 
Open
12.3 
1-M Low
11.51 
Market Cap 
10.32B 
Currency 美元 
P/E 29.9 
%Yield 0.68 
10-SMA 12.05 
20-SMA 12.06 
50-SMA 12.12 
52-W High 15.67 
52-W Low 11.36 
Exchange NYSE 
Valuation Estimation
EPS (Current/Estimated)
39.72/62.08
Enterprise Value
22.52B
Balance Sheet
Book Value Per Share
4.79
Cash Flow
Cash Flow Yield
0.04
Income Statement
Total Revenue
245.88B
Operating Revenue Per Share
3.85
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
APUSApimeds Pharmaceuticals US Inc.4.92+2.63+114.85%-- 
After Hours 4.87 -0.05 -1.02%
HLNHaleon plc9.215+0.105+1.15%19PE
After Hours 9.22 -- --
HIMSHims & Hers Health29.26+0.87+3.06%-- 
After Hours 29.19 -- --
VTRSViatris17.42+0.3+1.75%-- 
After Hours 17.3658 -- --
PRGOPerrigo Company PLC14.68+0.84+6.07%-- 
After Hours 14.68 -- --
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly 40% of its generics sales, with other key markets being India (20%) and Europe (20%).Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand nameand earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.